Skip to main content
Signal8

GOLDENWELL BIOTECH, INC. (GWLL)

Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. It is developing JI MAI, a bovine cardiac vascular active peptide; Double Proline AG, a 3D active collagen peptide drinkable cosmetic; Cartilage Peptide, a Type II collagen peptide; and Sugar Master, a dietary supplement. The company was incorporated in 2019 and is based in Hudson, Ohio.

Sector: Food and Kindred Products

Industry: Medical - Pharmaceuticals

Goldenwell Biotech, Inc. logo

Goldenwell Biotech, Inc.

OTC:GWLLHealthcare
Mkt Cap$64.35M
Float2.15M
O/S99M
Inst Own-
Dilution
FormDescription
13D
3
Initial Statement of Beneficial Ownership
8-K
8-K
10-Q
10-Q
10-K
10-Q/A
Quarterly Report (Amended)
5
10-Q/A
Quarterly Report (Amended)
5
10-Q/A
Quarterly Report (Amended)
5
8-K
NT 10-Q
SEC Filing
2
NT 10-K
SEC Filing
10-Q
Quarterly Report
10-Q
Quarterly Report
8-K
4.01,9.01
NT 10-Q
SEC Filing
10-Q
Quarterly Report
10-K
Annual Report
NT 10-Q
SEC Filing
NT 10-K
SEC Filing
8-K
4.01,9.01
10-Q
Quarterly Report
8-K
4.01,9.01
NT 10-Q
SEC Filing

1-25 of 85